Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

The IARC Monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification.

Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Curieux FL, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, Ghissassi FE, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP.

J Natl Cancer Inst. 2019 Sep 9. pii: djz169. doi: 10.1093/jnci/djz169. [Epub ahead of print]

PMID:
31498409
2.

Centralization of the IARC Biobank: Combining Multiple Sample Collections into a Common Platform.

Mendy M, Caboux E, Wild CP; IARC Biobank Steering Committee Members.

Biopreserv Biobank. 2019 May 15. doi: 10.1089/bio.2018.0036. [Epub ahead of print]

PMID:
31091138
3.

Boosting the social impact of innovative cancer research - towards a mission-oriented approach to cancer.

Ringborg U, Celis JE, Baumann M, Eggermont A, Wild CP, Berns A.

Mol Oncol. 2019 Mar;13(3):497-501. doi: 10.1002/1878-0261.12464. Epub 2019 Feb 27. No abstract available.

4.

The global cancer burden: necessity is the mother of prevention.

Wild CP.

Nat Rev Cancer. 2019 Mar;19(3):123-124. doi: 10.1038/s41568-019-0110-3. No abstract available.

PMID:
30683893
5.

Cancer Prevention Europe.

Wild CP, Espina C, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Forman D, Kampman E, Nilbert M, Steindorf K, Storm H, Vineis P, Baumann M, Schüz J.

Mol Oncol. 2019 Mar;13(3):528-534. doi: 10.1002/1878-0261.12455. Epub 2019 Feb 13. Review.

6.

Primary prevention: a need for concerted action.

Schüz J, Espina C, Wild CP.

Mol Oncol. 2019 Mar;13(3):567-578. doi: 10.1002/1878-0261.12432. Epub 2019 Jan 18. Review.

7.

Trends of serum phospholipid fatty acids over time in rural Uganda: evidence of nutritional transition?

Chajès V, Gibson LJ, Biessy C, Slimani N, Asiki G, Dossus L, Wild CP, Newton R.

Br J Nutr. 2019 Jan;121(2):130-136. doi: 10.1017/S0007114518003227. Epub 2018 Nov 27.

PMID:
30477593
8.

Impaired growth in rural Gambian infants exposed to aflatoxin: a prospective cohort study.

Watson S, Moore SE, Darboe MK, Chen G, Tu YK, Huang YT, Eriksen KG, Bernstein RM, Prentice AM, Wild CP, Xu Y, Routledge MN, Gong YY.

BMC Public Health. 2018 Nov 9;18(1):1247. doi: 10.1186/s12889-018-6164-4.

9.

Toward the World Code Against Cancer.

Espina C, Herrero R, Sankaranarayanan R, Krug E, Wild CP, Schüz J.

J Glob Oncol. 2018 Sep;4:1-8. doi: 10.1200/JGO.17.00145.

10.

Reducing Social Inequalities in Cancer: Setting Priorities for Research.

Vaccarella S, Lortet-Tieulent J, Saracci R, Fidler MM, Conway DI, Vilahur N, Sarfati D, Jemal A, Mackenbach JP, Marmot MG, Straif K, Wild CP.

CA Cancer J Clin. 2018 Sep;68(5):324-326. doi: 10.3322/caac.21463. Epub 2018 Jul 10. No abstract available.

11.

Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar.

Selmouni F, Zidouh A, Belakhel L, Sauvaget C, Bennani M, Khazraji YC, Benider A, Wild CP, Bekkali R, Fadhil I, Sankaranarayanan R.

Lancet Oncol. 2018 Feb;19(2):e93-e101. doi: 10.1016/S1470-2045(17)30727-1. Review.

PMID:
29413484
12.

International cancer seminars: a focus on esophageal squamous cell carcinoma.

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, Gopal S, Hashemian M, Hu N, Hyland PL, Kaimila B, Kamangar F, Malekzadeh R, Mathew CG, Menya D, Mulima G, Mwachiro MM, Mwasamwaja A, Pritchett N, Qiao YL, Ribeiro-Pinto LF, Ricciardone M, Schüz J, Sitas F, Taylor PR, Van Loon K, Wang SM, Wei WQ, Wild CP, Wu C, Abnet CC, Chanock SJ, Brennan P.

Ann Oncol. 2017 Sep 1;28(9):2086-2093. doi: 10.1093/annonc/mdx279. Review.

13.

Roadmap for investigating epigenome deregulation and environmental origins of cancer.

Herceg Z, Ghantous A, Wild CP, Sklias A, Casati L, Duthie SJ, Fry R, Issa JP, Kellermayer R, Koturbash I, Kondo Y, Lepeule J, Lima SCS, Marsit CJ, Rakyan V, Saffery R, Taylor JA, Teschendorff AE, Ushijima T, Vineis P, Walker CL, Waterland RA, Wiemels J, Ambatipudi S, Degli Esposti D, Hernandez-Vargas H.

Int J Cancer. 2018 Mar 1;142(5):874-882. doi: 10.1002/ijc.31014. Epub 2017 Sep 13. Review.

14.

The science of precision prevention of cancer.

Vineis P, Wild CP.

Lancet Oncol. 2017 Aug;18(8):997-998. doi: 10.1016/S1470-2045(17)30331-5. Epub 2017 Jul 26. No abstract available.

PMID:
28759370
15.

Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines.

Hernandez-Vargas H, Gruffat H, Cros MP, Diederichs A, Sirand C, Vargas-Ayala RC, Jay A, Durand G, Le Calvez-Kelm F, Herceg Z, Manet E, Wild CP, Tommasino M, Accardi R.

Sci Rep. 2017 Jul 19;7(1):5852. doi: 10.1038/s41598-017-05713-2.

16.

Classification schemes for carcinogenicity based on hazard identification serve science and society.

Loomis D, Guyton KZ, Straif K, Wild CP.

Regul Toxicol Pharmacol. 2017 Aug;88:356-357. doi: 10.1016/j.yrtph.2017.02.010. Epub 2017 Feb 16. No abstract available.

17.

The exposome in practice: Design of the EXPOsOMICS project.

Vineis P, Chadeau-Hyam M, Gmuender H, Gulliver J, Herceg Z, Kleinjans J, Kogevinas M, Kyrtopoulos S, Nieuwenhuijsen M, Phillips DH, Probst-Hensch N, Scalbert A, Vermeulen R, Wild CP; EXPOsOMICS Consortium.

Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):142-151. doi: 10.1016/j.ijheh.2016.08.001. Epub 2016 Aug 19.

18.

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.

Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L.

N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412. No abstract available.

PMID:
27532827
19.

Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Hollstein M, Alexandrov LB, Wild CP, Ardin M, Zavadil J.

Oncogene. 2017 Jan 12;36(2):158-167. doi: 10.1038/onc.2016.192. Epub 2016 Jun 6. Review.

20.

Liver Cancer.

Gelband H, Chen CJ, Chen W, Franceschi S, Hall SA, London WT, McGlynn KA, Wild CP.

In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 8.

21.

Fifty years of the International Agency for Research on Cancer (1965 to 2015).

Saracci R, Wild CP.

Int J Cancer. 2016 Mar 15;138(6):1309-11. doi: 10.1002/ijc.29929. Epub 2015 Nov 28. No abstract available.

22.

Cancer prevention as part of precision medicine: 'plenty to be done'.

Stewart BW, Bray F, Forman D, Ohgaki H, Straif K, Ullrich A, Wild CP.

Carcinogenesis. 2016 Jan;37(1):2-9. doi: 10.1093/carcin/bgv166. Epub 2015 Nov 20. Review.

23.

Genomics of Cancer and a New Era for Cancer Prevention.

Brennan P, Wild CP.

PLoS Genet. 2015 Nov 5;11(11):e1005522. doi: 10.1371/journal.pgen.1005522. eCollection 2015 Nov. Review.

24.

The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models.

Accardi R, Gruffat H, Sirand C, Fusil F, Gheit T, Hernandez-Vargas H, Le Calvez-Kelm F, Traverse-Glehen A, Cosset FL, Manet E, Wild CP, Tommasino M.

Carcinogenesis. 2015 Nov;36(11):1440-51. doi: 10.1093/carcin/bgv142. Epub 2015 Sep 30.

PMID:
26424750
25.

Exposure to aflatoxin B1 in utero is associated with DNA methylation in white blood cells of infants in The Gambia.

Hernandez-Vargas H, Castelino J, Silver MJ, Dominguez-Salas P, Cros MP, Durand G, Le Calvez-Kelm F, Prentice AM, Wild CP, Moore SE, Hennig BJ, Herceg Z, Gong YY, Routledge MN.

Int J Epidemiol. 2015 Aug;44(4):1238-48. doi: 10.1093/ije/dyv027. Epub 2015 Apr 7.

26.

Translational cancer research: balancing prevention and treatment to combat cancer globally.

Wild CP, Bucher JR, de Jong BW, Dillner J, von Gertten C, Groopman JD, Herceg Z, Holmes E, Holmila R, Olsen JH, Ringborg U, Scalbert A, Shibata T, Smith MT, Ulrich C, Vineis P, McLaughlin J.

J Natl Cancer Inst. 2014 Dec 16;107(1):353. doi: 10.1093/jnci/dju353. Print 2015 Jan.

27.

Cancer in the 25×25 non-communicable disease targets.

Wild CP, Bray F, Forman D, Franceschi S, Sankaranarayanan R, Straif K.

Lancet. 2014 Oct 25;384(9953):1502-3. doi: 10.1016/S0140-6736(14)61918-8. No abstract available.

PMID:
25390574
28.

A prospective study of growth and biomarkers of exposure to aflatoxin and fumonisin during early childhood in Tanzania.

Shirima CP, Kimanya ME, Routledge MN, Srey C, Kinabo JL, Humpf HU, Wild CP, Tu YK, Gong YY.

Environ Health Perspect. 2015 Feb;123(2):173-8. doi: 10.1289/ehp.1408097. Epub 2014 Oct 17. Erratum in: Environ Health Perspect. 2015 Feb;123(2):A32. Tu, Yu-Kang [added].

29.

Cancer control: a reminder of the need for a balanced approach between prevention and treatment.

Wild CP.

East Mediterr Health J. 2014 Jun 18;20(6):360-2. No abstract available.

30.

Quantitative correlation of aflatoxin biomarker with dietary intake of aflatoxin in Tanzanian children.

Routledge MN, Kimanya ME, Shirima CP, Wild CP, Gong YY.

Biomarkers. 2014 Aug;19(5):430-5. doi: 10.3109/1354750X.2014.924998. Epub 2014 Jun 5.

PMID:
24902045
31.

Aflatoxin exposure is inversely associated with IGF1 and IGFBP3 levels in vitro and in Kenyan schoolchildren.

Castelino JM, Routledge MN, Wilson S, Dunne DW, Mwatha JK, Gachuhi K, Wild CP, Gong YY.

Mol Nutr Food Res. 2015 Mar;59(3):574-81. doi: 10.1002/mnfr.201300619. Epub 2014 Jan 25.

32.

Building capacity for sustainable research programmes for cancer in Africa.

Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, Parkin DM, Rebbeck TR, Ross H, Santini LA, Torode J, Trimble EL, Wild CP, Young AM, Kerr DJ.

Nat Rev Clin Oncol. 2014 May;11(5):251-9. doi: 10.1038/nrclinonc.2014.37. Epub 2014 Mar 11. Review.

33.

A pilot study to evaluate aflatoxin exposure in a rural Ugandan population.

Asiki G, Seeley J, Srey C, Baisley K, Lightfoot T, Archileo K, Agol D, Abaasa A, Wakeham K, Routledge MN, Wild CP, Newton R, Gong YY.

Trop Med Int Health. 2014 May;19(5):592-9. doi: 10.1111/tmi.12283. Epub 2014 Feb 24.

34.

Seasonal and gestation stage associated differences in aflatoxin exposure in pregnant Gambian women.

Castelino JM, Dominguez-Salas P, Routledge MN, Prentice AM, Moore SE, Hennig BJ, Wild CP, Gong YY.

Trop Med Int Health. 2014 Mar;19(3):348-354. doi: 10.1111/tmi.12250. Epub 2013 Dec 21.

35.

Global cancer patterns: causes and prevention.

Vineis P, Wild CP.

Lancet. 2014 Feb 8;383(9916):549-57. doi: 10.1016/S0140-6736(13)62224-2. Epub 2013 Dec 16. Review.

PMID:
24351322
36.

Dietary exposure to aflatoxin and fumonisin among Tanzanian children as determined using biomarkers of exposure.

Shirima CP, Kimanya ME, Kinabo JL, Routledge MN, Srey C, Wild CP, Gong YY.

Mol Nutr Food Res. 2013 Oct;57(10):1874-81. doi: 10.1002/mnfr.201300116. Epub 2013 Jun 17.

37.

Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Herceg Z, Lambert MP, van Veldhoven K, Demetriou C, Vineis P, Smith MT, Straif K, Wild CP.

Carcinogenesis. 2013 Sep;34(9):1955-67. doi: 10.1093/carcin/bgt212. Epub 2013 Jun 7. Review.

38.

Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk.

Wild CP, Scalbert A, Herceg Z.

Environ Mol Mutagen. 2013 Aug;54(7):480-99. doi: 10.1002/em.21777. Epub 2013 May 16. Review.

PMID:
23681765
39.

Meeting the global demands of epidemiologic transition - the indispensable role of cancer prevention.

Franceschi S, Wild CP.

Mol Oncol. 2013 Feb;7(1):1-13. doi: 10.1016/j.molonc.2012.10.010. Epub 2012 Nov 17. Review.

40.

Upper urinary tract urothelial cancers: where it is A:T.

Olivier M, Hollstein M, Schmeiser HH, Straif K, Wild CP.

Nat Rev Cancer. 2012 Aug;12(8):503-4. doi: 10.1038/nrc3311.

PMID:
23002458
41.

Do cervical cancer data justify human papillomavirus vaccination in India? epidemiological data sources and comprehensiveness.

Forman D, Franceschi S, Sankaranarayanan R, Bray F, Ferlay J, Dikshit R, Jha P, Wild CP.

J R Soc Med. 2012 Sep;105(9):365-6. doi: 10.1258/jrsm.2012.120207. No abstract available.

42.

The role of cancer research in noncommunicable disease control.

Wild CP.

J Natl Cancer Inst. 2012 Jul 18;104(14):1051-8. doi: 10.1093/jnci/djs262. Epub 2012 Jul 10.

43.

Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction?

Boylan SM, Greenwood DC, Alwan N, Cooke MS, Dolby VA, Hay AW, Kirk SF, Konje JC, Potdar N, Shires S, Simpson NA, Taub N, Thomas JD, Walker JJ, White KL, Wild CP, Cade JE.

Matern Child Health J. 2013 May;17(4):601-8. doi: 10.1007/s10995-012-1034-7.

44.

Evaluation of data quality at the Gambia national cancer registry.

Shimakawa Y, Bah E, Wild CP, Hall AJ.

Int J Cancer. 2013 Feb 1;132(3):658-65. doi: 10.1002/ijc.27646. Epub 2012 Jun 13.

45.

Aflatoxin exposure may contribute to chronic hepatomegaly in Kenyan school children.

Gong YY, Wilson S, Mwatha JK, Routledge MN, Castelino JM, Zhao B, Kimani G, Kariuki HC, Vennervald BJ, Dunne DW, Wild CP.

Environ Health Perspect. 2012 Jun;120(6):893-6. doi: 10.1289/ehp.1104357. Epub 2012 Feb 27.

46.

The exposome: from concept to utility.

Wild CP.

Int J Epidemiol. 2012 Feb;41(1):24-32. doi: 10.1093/ije/dyr236. Epub 2012 Jan 31. Review. No abstract available.

PMID:
22296988
47.

Preventable exposures associated with human cancers.

Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP.

J Natl Cancer Inst. 2011 Dec 21;103(24):1827-39. doi: 10.1093/jnci/djr483. Epub 2011 Dec 12. Review.

48.

A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent?

Sylla BS, Wild CP.

Int J Cancer. 2012 Jan 15;130(2):245-50. doi: 10.1002/ijc.26333. Epub 2011 Aug 30. Review.

49.

Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.

Villar S, Le Roux-Goglin E, Gouas DA, Plymoth A, Ferro G, Boniol M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P.

Environ Health Perspect. 2011 Nov;119(11):1635-40. doi: 10.1289/ehp.1103539. Epub 2011 Jul 18.

50.

Cancer survival in Africa, Asia, the Caribbean and Central America. Foreword.

Wild CP.

IARC Sci Publ. 2011;(162):VII. No abstract available.

PMID:
21675399

Supplemental Content

Support Center